In Jan., 2025, the vitamin market remained stable overall. Vitamin B1 remained a high price, which had been rising in Q4 2024. And Vitamin B2 began to rise after continuous price reduction in Q4 2024.
On 8 Jan., 2025, the National Medical Security Administration (NMSA) issued an announcement to amend the information of certain drugs in the National Medical Insurance, Work Injury Insurance, and Maternity Insurance Drug Catalog (2024).
Poly Pharm had been investigated by the China Securities Regulatory Commission (CSRC) for alleged violations of information disclosure regulations.
Blue Star Adisu Co., LTD (Adisseo, 600299), as a leader in the field of animal nutrition additives, has seen significant stock price fluctuations recently.
Project progress of many companies:
- Sanxia Proudin's biosynthetic amino acid, vitamin transformation project
- Dongbei Fufeng's glutamate efficient strain development and amino acid production line transformation project
- Benhan Biotech's 100 t/a vitamin B2 project
The USD/RMB exchange rate in this Report is USD1.00=CNY7.1879 on 2 Jan., 2025, sourced from the People's Bank of China. All the prices mentioned in this Report will include the VAT, unless otherwise specified.
Please purchase to view
Add to cart
